Novateur Ventures logo

Novateur Ventures

North America, British Columbia, Canada, Vancouver

Description

Novateur believes in the power of device and drug development that creates a virtual team which handles pharma partnerships.

Investor Profile

Novateur Ventures has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Novateur Ventures frequently co-invest with?

Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 2
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 2
Harrington Discovery Institute at University Hospitals
North America, Ohio, United States, Cleveland
Co-Investments: 2
Cambridge Innovation Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2
Investissement Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 1
adMare Bio Innovations
North America, British Columbia, Canada, Vancouver
Co-Investments: 1

Which angels does Novateur Ventures often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Novateur Ventures?

Epitopea

Cambridge, Cambridgeshire, United Kingdom

Epitopea is a transatlantic cancer immunotherapeutics company.

BiotechnologyLife ScienceTherapeutics
SeedOct 24, 2024
Amount Raised: $31,000,000
Epitopea

Cambridge, Cambridgeshire, United Kingdom

Epitopea is a transatlantic cancer immunotherapeutics company.

BiotechnologyLife ScienceTherapeutics
SeedApr 25, 2022
Amount Raised: $13,119,114